Clinical trial of porous bioactive titanium for lumbar spine fusio
Not Applicable
Completed
- Conditions
- umbar disc disease, lumbar spondylolisthesis, lumbar isthmic spondylolisthesis
- Registration Number
- JPRN-UMIN000001448
- Lead Sponsor
- Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1) No hip and leg disease 2) No cervical or thoracic spine disease 3) No previous lumbar spinal fusion 4) No collagen disease 5) BMI over 30 6) No pregnancy 7) No severe osteoporosis 8) No uncontrolable general disease 9) No malignacy 10) No psychological disease 11) No severe bacterial disease 12) No steroid treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraoperative handling of the implant and avoidance of iliac crest bone graft harvesting.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie porous bioactive titanium's role in promoting spinal fusion in lumbar disc disease?
How does porous bioactive titanium compare to autograft and allograft in lumbar spondylolisthesis treatment outcomes?
Are there specific biomarkers that predict successful osseointegration with porous bioactive titanium in spinal fusion?
What are the potential adverse events associated with porous bioactive titanium implants in lumbar fusion procedures?
What are the current trends in bioactive metal implants for spinal fusion compared to traditional bone grafting materials?